This Article Full Text Full Text (PDF) A correction has been published Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nysom, K. Articles by Mølgaard, C. Search for Related Content PubMed PubMed Citation Articles by Nysom, K. Articles by Mølgaard, C.

Degree of Fatness after Treatment for Acute Lymphoblastic Leukemia in Childhood¹

Section of Pediatric Hematology and Oncology (K.N., H.H.), the Section of Growth and Reproduction (K.H., J.M.), and the Pediatric Nutrition Unit (K.F.M.), The Juliane Marie Center, Rigshospitalet, DK-2100 Copenhagen; and the Research Department of Human Nutrition and Center for Advanced Food Studies, Royal Veterinary and Agricultural University (K.F.M., C.M.), DK-1958 Frederiksberg, Denmark

Address all correspondence and requests for reprints to: Dr. Karsten Nysom, Kurvej 16, DK-2880 Bagsværd, Denmark. E-mail: nysom{at}dadlnet.dk

Excessive fatness is considered a frequent late complication of treatment for childhood acute lymphoblastic leukemia. Most previous studies, however, were based on body mass index (BMI) rather than more direct fat mass measurements. We studied 95 survivors of childhood acute lymphoblastic leukemia a median of 11 yr (range, 3–23 yr) after diagnosis. BMI values at diagnosis, at cessation of therapy, yearly thereafter for up to 10 yr, and at follow-up were compared with French reference values. Whole body percent fat was measured at follow-up by dual energy x-ray absorptiometry and compared with data from 463 local controls. Adjusted for sex and age, the mean BMI increased significantly during therapy and remained largely unchanged thereafter. At follow-up, BMI did not differ significantly between patients and local controls. On the other hand, the whole body percent fat was significantly increased (mean observed/predicted value, 21.8/19.0%; P < 0.0002). Twenty-five patients (26%) had a percent fat above the 90th percentile of the reference values, which indicates excessive fatness. Adjusted for sex and age, a higher percent fat was related to cranial irradiation or GH insufficiency, but not to sex, the cumulative doses of anthracyclines or corticosteroids, or the type of corticosteroid used. BMI was a poor measure of body fatness.

This article has been cited by other articles:

				L. Diller, E. J. Chow, J. G. Gurney, M. M. Hudson, N. S. Kadin-Lottick, T. I. Kawashima, W. M. Leisenring, L. R. Meacham, A. C. Mertens, D. A. Mulrooney, et al. Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings J. Clin. Oncol., May 10, 2009; 27(14): 2339 - 2355. [Full Text] [PDF]

				E. G. Garmey, Q. Liu, C. A. Sklar, L. R. Meacham, A. C. Mertens, M. A. Stovall, Y. Yasui, L. L. Robison, and K. C. Oeffinger Longitudinal Changes in Obesity and Body Mass Index Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., October 1, 2008; 26(28): 4639 - 4645. [Abstract] [Full Text] [PDF]

				G. T. Armstrong, C. A. Sklar, M. M. Hudson, and L. L. Robison Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter? J. Clin. Oncol., October 1, 2007; 25(28): 4477 - 4489. [Abstract] [Full Text] [PDF]

				R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF]

				K. A. Neville, R. J. Cohn, K. S. Steinbeck, K. Johnston, and J. L. Walker Hyperinsulinemia, Impaired Glucose Tolerance, and Diabetes Mellitus in Survivors of Childhood Cancer: Prevalence and Risk Factors J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4401 - 4407. [Abstract] [Full Text] [PDF]

				A. J Murphy, J. C. Wells, J. E Williams, M. S Fewtrell, P. S. Davies, and D. K Webb Body composition in children in remission from acute lymphoblastic leukemia Am. J. Clinical Nutrition, January 1, 2006; 83(1): 70 - 74. [Abstract] [Full Text] [PDF]

				E. J. Ladas, N. Sacks, L. Meacham, D. Henry, L. Enriquez, G. Lowry, R. Hawkes, G. Dadd, and P. Rogers A Multidisciplinary Review of Nutrition Considerations in the Pediatric Oncology Population: A Perspective From Children's Oncology Group Nutr Clin Pract, August 1, 2005; 20(4): 377 - 393. [Abstract] [Full Text] [PDF]

				M Jarfelt, B Lannering, I Bosaeus, G Johannsson, and R Bjarnason Body composition in young adult survivors of childhood acute lymphoblastic leukaemia Eur. J. Endocrinol., July 1, 2005; 153(1): 81 - 89. [Abstract] [Full Text] [PDF]

				D. Marinovic, S. Dorgeret, B. Lescoeur, C. Alberti, M. Noel, P. Czernichow, G. Sebag, E. Vilmer, and J. Leger Improvement in Bone Mineral Density and Body Composition in Survivors of Childhood Acute Lymphoblastic Leukemia: A 1-Year Prospective Study Pediatrics, July 1, 2005; 116(1): e102 - e108. [Abstract] [Full Text] [PDF]

				D. M. Greving and S. J. Santacroce Cardiovascular Late Effects Journal of Pediatric Oncology Nursing, January 1, 2005; 22(1): 38 - 47. [Abstract] [PDF]

				K. C. Oeffinger and M. M. Hudson Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236. [Abstract] [Full Text] [PDF]

				A. B. Sopher, J. C. Thornton, J. Wang, R. N. Pierson Jr, S. B. Heymsfield, and M. Horlick Measurement of Percentage of Body Fat in 411 Children and Adolescents: A Comparison of Dual-Energy X-Ray Absorptiometry With a Four-Compartment Model Pediatrics, May 1, 2004; 113(5): 1285 - 1290. [Abstract] [Full Text] [PDF]

				R. H. Lustig, P. S. Hinds, K. Ringwald-Smith, R. K. Christensen, S. C. Kaste, R. E. Schreiber, S. N. Rai, S. Y. Lensing, S. Wu, and X. Xiong Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2586 - 2592. [Abstract] [Full Text] [PDF]

				K. C. Oeffinger, A. C. Mertens, C. A. Sklar, Y. Yasui, T. Fears, M. Stovall, T. A. Vik, P. D. Inskip, and L. L. Robison Obesity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study J. Clin. Oncol., April 1, 2003; 21(7): 1359 - 1365. [Abstract] [Full Text] [PDF]

				R. H. Lustig, S. R. Post, K. Srivannaboon, S. R. Rose, R. K. Danish, G. A. Burghen, X. Xiong, S. Wu, and T. E. Merchant Risk Factors for the Development of Obesity in Children Surviving Brain Tumors J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 611 - 616. [Abstract] [Full Text] [PDF]

				J. J. Reilly, M. Brougham, C. Montgomery, F. Richardson, A. Kelly, and B. E. S. Gibson Effect of Glucocorticoid Therapy on Energy Intake in Children Treated for Acute Lymphoblastic Leukemia J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3742 - 3745. [Abstract] [Full Text] [PDF]

				J. J. Reilly, A. Kelly, P. Ness, A. R. Dorosty, W. H. B. Wallace, B. E. S. Gibson, and P. M. Emmett Premature Adiposity Rebound in Children Treated for Acute Lymphoblastic Leukemia J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2775 - 2778. [Abstract] [Full Text] [PDF]